Information  X 
Enter a valid email address

Chemring Group PLC (CHG)

  Print          Annual reports

Friday 02 October, 2020

Chemring Group PLC

Director/PDMR Shareholding

RNS Number : 9544A
Chemring Group PLC
02 October 2020
 

2 October 2020

 

Chemring Group PLC

 

Exercise of sharesave options and sale of shares

 

 

Chemring Group PLC ("Chemring" or "the Company") announces that on 1 October 2020 Andrew Lewis and Sarah Ellard, directors of the Company, exercised options granted under the Chemring Group 2008 UK Sharesave Plan on 27 July 2017 and today sold shares as detailed below. 

 

The following table details the transactions which were notified to the Company:

 

Director

Options exercised

Number of shares sold

Resultant beneficial interest in the Company's shares

Andrew Lewis

12,162

12,162

113,797

Sarah Ellard

7,297

5,000

107,700

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Andrew Lewis

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Exercise of options granted on 27 July 2017

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

148p exercise price

 

12,162

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

1 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Andrew Lewis

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Sale of shares following exercise of options 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

233p

 

12,162

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

  Exercise of options granted on 27 July 2017

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

148p exercise price

 

7,297

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

1 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

  Sale of shares following exercise of options 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

233p

 

5,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2 October 2020

f)

 

Place of the transaction

 

 

UK

 

 

 

 

For further information:

Chemring Group PLC

 

Sarah Ellard

Group Legal Director

+44 (0)1794 833 901

     

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFVAISLFIII

a d v e r t i s e m e n t